ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 3593

$1.39M Total Retail Price of All Prescriptions

Rank: 63 out of 3593

787 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 787 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 787 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 14,129 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,500 709 S3 1 7
OXYCODONE HCL 1,024 232 S2 2 59
AMLODIPINE BESYLATE 1,000 713 3 3
SIMVASTATIN 966 691 4 1
LISINOPRIL 952 601 5 2
OMEPRAZOLE 820 449 6 5
ZOLPIDEM TARTRATE 583 201 7 12
FUROSEMIDE 555 360 8 9
METOPROLOL TARTRATE 544 385 9 8
OXYCODONE HCL-ACETAMINOPHEN 468 107 S2 10 82
CARISOPRODOL 441 53 R 11 97
LEVOTHYROXINE SODIUM 420 263 12 4
METFORMIN HCL 415 258 13 6
GABAPENTIN 347 164 14 16
ATENOLOL 336 270 15 11
MORPHINE SULFATE ER 308 48 S2 16 108
HYDROCHLOROTHIAZIDE 276 208 17 10
VENTOLIN HFA 275 126 18 80
GLIMEPIRIDE 259 162 19 44
BENAZEPRIL HCL 255 170 20 69
CARVEDILOL 246 125 21 23
CITALOPRAM HBR 243 101 22 25
POTASSIUM CHLORIDE 240 149 23 24
PRAVASTATIN SODIUM 223 169 24 13
LOVASTATIN 206 188 25 20
TRAMADOL HCL 201 156 26 17
WARFARIN SODIUM 199 141 27 18
METOPROLOL SUCCINATE 197 130 28 19
PROAIR HFA 192 64 29 54
OXYCONTIN 191 34 S2 30 166
SERTRALINE HCL 190 86 31 28
CYCLOBENZAPRINE HCL 178 67 R 32 72
DICLOFENAC SODIUM 171 93 33 74
LOSARTAN POTASSIUM 170 155 34 14
ENALAPRIL MALEATE 169 106 35 38
FENOFIBRATE 169 112 35 39
FLUTICASONE PROPIONATE 168 77 37 32
HYDROMORPHONE HCL 165 39 S2 38 171
TIZANIDINE HCL 160 65 39 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 155 79 40 26
FENTANYL 155 43 S2 40 137
ADVAIR DISKUS 153 97 42 47
TRIAMTERENE-HCTZ 152 78 43 66
ATORVASTATIN CALCIUM 151 87 44 15
RANITIDINE HCL 141 88 45 27
DOXAZOSIN MESYLATE 139 110 46 63
GLIPIZIDE 139 94 46 40
CLOPIDOGREL 135 68 48 30
MELOXICAM 132 101 49 29
AZITHROMYCIN 130 59 50 34
FLUOXETINE HCL 128 72 51 60
DIGOXIN 125 76 52 58
ISOSORBIDE MONONITRATE ER 123 89 53 61
PROMETHAZINE HCL 122 42 R 54 142
METHADONE HCL 120 0 S2 55 158
ALPRAZOLAM 119 38 56 37
KLOR-CON 10 113 70 57 114
MORPHINE SULFATE 112 0 S2 58 240
AMOXICILLIN 110 55 59 128
IBUPROFEN 105 68 60 43
TRAZODONE HCL 104 50 61 53
PAROXETINE HCL 102 41 62 62
BENAZEPRIL-HYDROCHLOROTHIAZIDE 102 61 62 257
TAMSULOSIN HCL 100 76 64 33
PLAVIX 99 52 65 42
CLONIDINE HCL 97 61 66 41
GLYBURIDE-METFORMIN HCL 94 89 R 67 95
LANTUS 93 49 68 57
PREDNISONE 92 50 69 49
CRESTOR 90 70 70 21
ROPINIROLE HCL 90 52 70 144
NIFEDIPINE ER 88 82 72 75
CYMBALTA 87 0 73 73
AMITRIPTYLINE HCL 87 64 R 73 90
CEFUROXIME 87 38 73 254
CIPROFLOXACIN HCL 83 55 76 52
PANTOPRAZOLE SODIUM 83 30 76 45
GEMFIBROZIL 81 63 78 88
AMLODIPINE BESYLATE-BENAZEPRIL 81 45 78 65
FAMOTIDINE 80 63 80 70
AMOX TR-POTASSIUM CLAVULANATE 80 42 80 138
METFORMIN HCL ER 80 59 80 67
OXYBUTYNIN CHLORIDE 80 80 80 104
TERAZOSIN HCL 79 71 84 115
ALENDRONATE SODIUM 77 60 85 22
ALLOPURINOL 77 37 85 35
GLIPIZIDE ER 75 61 87 101
HYDRALAZINE HCL 73 55 88 107
FELODIPINE ER 71 54 89 229
HUMULIN 70-30 71 69 89 215
INSULIN SYRINGE 71 39 89 91
METHYLPREDNISOLONE 71 44 89 103
PHENYTOIN SODIUM EXTENDED 69 40 93 165
TRIAMTERENE-HYDROCHLOROTHIAZID 69 31 93 231
ESTRADIOL 68 43 R 95 174
ETODOLAC 67 37 96 247
DONEPEZIL HCL 67 66 96 31
SYMBICORT 66 18 98 160
JANUVIA 65 31 99 81
NEXIUM 63 27 100 36
SINGULAIR 61 27 101 77
SPIRIVA 60 35 102 87
CILOSTAZOL 60 39 102 163
PREMARIN 59 38 R 104 204
LOSARTAN-HYDROCHLOROTHIAZIDE 59 32 104 48
BUSPIRONE HCL 59 26 104 156
JANTOVEN 56 44 107 169
MIRTAZAPINE 56 25 107 64
FINASTERIDE 54 41 109 79
LIPITOR 54 28 109 136
HYDROXYZINE HCL 54 34 R 109 196
GLIPIZIDE XL 51 49 112 179
SPIRONOLACTONE 50 24 113 86
METOCLOPRAMIDE HCL 50 13 113 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.